IL3RA and leukemia: Figure 3A shows that CAR.CD123-NK cells were able to exert significant leukaemia cytotoxicity towards CD123+ blasts derived from all 3 AML patients (Additional file 1: Fig. S5), with minimal variability (CAR.CD123-NK; St Dv = 7.4).